Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 20956 | 378 | 23.3 | 69% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 708 | 12194 | CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AMLODIPINE | Author keyword | 13 | 10% | 31% | 118 |
| 2 | DILTIAZEM CR | Author keyword | 2 | 67% | 1% | 2 |
| 3 | BESYLATE | Author keyword | 1 | 50% | 1% | 2 |
| 4 | CHANZHENG HOSP | Address | 1 | 50% | 0% | 1 |
| 5 | CLIN MED 2 INTERNAL MED THER EUT | Address | 1 | 50% | 0% | 1 |
| 6 | FELODIPINE EXTENDED RELEASE | Author keyword | 1 | 50% | 0% | 1 |
| 7 | MCN A343 | Author keyword | 1 | 50% | 0% | 1 |
| 8 | MED SCI ALAGOAS | Address | 1 | 50% | 0% | 1 |
| 9 | MODERATE SEVERE HYPERTENSION | Author keyword | 1 | 50% | 0% | 1 |
| 10 | MORBIDITY PROFILE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AMLODIPINE | 13 | 10% | 31% | 118 | Search AMLODIPINE | Search AMLODIPINE |
| 2 | DILTIAZEM CR | 2 | 67% | 1% | 2 | Search DILTIAZEM+CR | Search DILTIAZEM+CR |
| 3 | BESYLATE | 1 | 50% | 1% | 2 | Search BESYLATE | Search BESYLATE |
| 4 | FELODIPINE EXTENDED RELEASE | 1 | 50% | 0% | 1 | Search FELODIPINE+EXTENDED+RELEASE | Search FELODIPINE+EXTENDED+RELEASE |
| 5 | MCN A343 | 1 | 50% | 0% | 1 | Search MCN+A343 | Search MCN+A343 |
| 6 | MODERATE SEVERE HYPERTENSION | 1 | 50% | 0% | 1 | Search MODERATE+SEVERE+HYPERTENSION | Search MODERATE+SEVERE+HYPERTENSION |
| 7 | MORBIDITY PROFILE | 1 | 50% | 0% | 1 | Search MORBIDITY+PROFILE | Search MORBIDITY+PROFILE |
| 8 | NIFEDIPINE CONTROLLED RELEASE | 1 | 50% | 0% | 1 | Search NIFEDIPINE+CONTROLLED+RELEASE | Search NIFEDIPINE+CONTROLLED+RELEASE |
| 9 | NIFEDIPINE EXTENDED RELEASE | 1 | 50% | 0% | 1 | Search NIFEDIPINE+EXTENDED+RELEASE | Search NIFEDIPINE+EXTENDED+RELEASE |
| 10 | QUANTASCOPE | 1 | 50% | 0% | 1 | Search QUANTASCOPE | Search QUANTASCOPE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PARALLEL DOSE RESPONSE | 20 | 100% | 2% | 9 |
| 2 | EXERTIONAL ANGINA PECTORIS | 1 | 40% | 1% | 2 |
| 3 | REFLEX CARDIAC CONTROL | 1 | 50% | 0% | 1 |
| 4 | DAILY CALCIUM ANTAGONIST | 0 | 33% | 0% | 1 |
| 5 | ANTAGONIST NIFEDIPINE | 0 | 15% | 1% | 2 |
| 6 | METOPROLOL PHARMACOKINETICS | 0 | 20% | 0% | 1 |
| 7 | ONE CLIP RATS | 0 | 20% | 0% | 1 |
| 8 | RELEASE NIFEDIPINE | 0 | 17% | 0% | 1 |
| 9 | HEMODYNAMIC OVERLOAD | 0 | 14% | 0% | 1 |
| 10 | PRESSOR DOSE RESPONSE | 0 | 14% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| AMLODIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN CARDIOVASCULAR-DISEASE | 1991 | 143 | 83 | 58% |
| AMLODIPINE - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR-DISEASE | 1995 | 98 | 123 | 60% |
| Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS | 2012 | 8 | 50 | 36% |
| Effect of amlodipine on systolic blood pressure | 2003 | 18 | 106 | 33% |
| Amlodipine - An overview | 1997 | 9 | 77 | 60% |
| Single-dose, randomized, crossover bioequivalence study of amlodipine maleate versus amlodipine besylate in healthy volunteers | 2007 | 4 | 20 | 35% |
| Relevance of 24 H blood pressure profile and sympathetic activity for outcome on short- versus long-acting 1,4-dihydropyridines | 1996 | 33 | 59 | 20% |
| Anti hypertensive drugs and the sympathetic nervous system | 2007 | 12 | 99 | 12% |
| Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs | 2012 | 14 | 43 | 7% |
| Amlodipine in Contemporary Therapy of Cardiovascular Diseases | 2010 | 0 | 16 | 25% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHANZHENG HOSP | 1 | 50% | 0.3% | 1 |
| 2 | CLIN MED 2 INTERNAL MED THER EUT | 1 | 50% | 0.3% | 1 |
| 3 | MED SCI ALAGOAS | 1 | 50% | 0.3% | 1 |
| 4 | CLIN CHILDRENS INTERNAL DIS | 0 | 20% | 0.3% | 1 |
| 5 | EXPT PATHOMORPHOL | 0 | 17% | 0.3% | 1 |
| 6 | CLIN HOSP BEZANIJSKA KOSA | 0 | 14% | 0.3% | 1 |
| 7 | SAN VITO HOSP | 0 | 11% | 0.3% | 1 |
| 8 | HELIOS KLINIKEN | 0 | 10% | 0.3% | 1 |
| 9 | PEDRO ERNESTO HOSP | 0 | 10% | 0.3% | 1 |
| 10 | SECT CLIN PHARM | 0 | 10% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000234388 | FELODIPINE//NORMOTENSIVE VOLUNTEERS//ARANIDIPINE |
| 2 | 0.0000232925 | LERCANIDIPINE//LACIDIPINE//LERCANIDIPINE HYDROCHLORIDE |
| 3 | 0.0000223287 | CILNIDIPINE//BENIDIPINE//AZELNIDIPINE |
| 4 | 0.0000164300 | MEBUDIPINE//BARNIDIPINE HYDROCHLORIDE//BARNIDIPINE |
| 5 | 0.0000159522 | HYDROCHLOROTHIAZIDE//AMLODIPINE BESYLATE//LOSARTAN POTASSIUM |
| 6 | 0.0000156246 | ELGODIPINE//NISOLDIPINE//GALLOPAMIL |
| 7 | 0.0000150806 | PRANIDIPINE//OPC 13340//CAS 99522 79 9 |
| 8 | 0.0000109691 | ANTIOXIDANT PHARMACOL//NITROSONIFEDIPINE//MYOCYTE MIGRATION |
| 9 | 0.0000100481 | ISRADIPINE//CAS 75695 93 1//DENSITY DEPENDENT GROWTH INHIBITION |
| 10 | 0.0000087901 | AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY |